Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) was down 19% during trading on Tuesday . The stock traded as low as $1.62 and last traded at $1.62. Approximately 300 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 75,729 shares. The stock had previously closed at $2.00.
Mesoblast Stock Performance
The business’s 50 day moving average price is $1.80 and its 200 day moving average price is $1.17.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
See Also
- Five stocks we like better than Mesoblast
- CD Calculator: Certificate of Deposit Calculator
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Canadian Penny Stocks: Can They Make You Rich?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Transportation Stocks Investing
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
